Joslin Diabetes Center is the world's leading diabetes research and clinical care organization, focused on preventing and curing Type 1 and Type 2 Diabetes and their long-term complications.
When Joslin needed assistance protecting and commercializing its technology it came to Pierce Atwood. Will Worden provides Joslin's in-house team with on-going direction regarding research collaboration, licensing agreements, material transfers, joint ventures and software development.
Will was a trailblazer in defining the legal aspects of stem cell research and has real-world experience managing large husbandry operations. His combination of scientific training, practical business experience, and legal acumen has proven to be a solid recipe for grounded, sophisticated legal advice.